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Theophyiline (THEOP), a natural compo-
nent in tea that also finds pharmaceutical
use as a bronchodilator, vasodilator, and a
smooth muscle relaxant, was tested for its
effects on reproduction and fertility in
Swiss CD-1 mice using the RACB protocol
(Morrissey et al., Fundam Appl Toxicol
10:525-536 [1988]). Data on food and
water consumptions, body weights, and
clinical signs during a 2-week dose-range-
finding study (Task 1) were used to set
exposure concentrations for theTask 2 con-
tinuous cohabitation study at 0.075, 0.15,
and 0.3% weight per volume in feed. Feed
consumption was not altered by THEOP
addition. These levels gave calculated con-
sumption estimates ofapproximately 126,
260, and 500 mgTHEOP/kg/day.
Alopecia occurred in both sexes ofall
groups oftreated animals (20-25% in the
0.075 group, and >50% in the 0.15 and
0.3% groups). Seven mice died during
Task 2: three controls, and four in the low
dose group. Asingle control mouse showed
alopecia; this was less severe than that see
in the treated mice.
Significant reproductive effects were
observed: there was a 19% reduction in the
mean number of litters per pair for the
high dose mice, fewer live pups per litter at
all doses (reduced by 22, 29, and 42% in
the low and high dose groups, respec-
tively), and, at the highest concentration
level, a 6% decrease in live pup weight
adjusted for litter size. The number ofdays
to the delivery of each litter was consis-
tently greater in the 0.3% THEOP group,
which was 3 days longer for the first litter,
5 days longer for the last litter, and simi-
larlyincreased forall otherlitters.
Given the significant effects on repro-
ductive performance, a crossover mating
was used in an attempt to identify the
affected sex. In this mating trial, there were
no differences in the percent ofpairs mat-
ing or delivering a live litter. However, in
the group cohabiting control males and
0.3% exposed females, the proportion of
pups born alive was reduced by 16%, and
the adjusted live pup weight was reduced
by 15%.
After the litters in Task 3 were deliv-
ered, evaluated, and discarded, the females
were evaluated for vaginal cyclicity for 7
days, and then the Fo mice in the control
and 0.3% theophylline groups were killed
and necropsied. There was a 5% increase
in female terminal body weights in the
0.3% THEOP group, and an 11% increase
in liver weight adjusted for body weight.
Interestingly, there were no changes in the
length ofthe estrous cyde, or in the percent
oftime spent in the various estrous stages.
Treated male terminal body weights were
reduced by 7% versus controls. Body
weight-adjusted seminal vesicle weight
decreased by 19%. Epididymal sperm
density was reduced by 20% in the high
dose group; the percent motile and the per-
cent ofabnormal morphologic forms were
unchangedby0.3% THEOP exposure.
No second-generation analysis was
conducted.
In summary, theophylline at these lev-
els of intake caused significant adverse
reproductive effects (fewer live pups per lit-
ter, with reduced pup weight and fewer lit-
ters per pair at the high dose, as well as
reduced seminal vesicle weight and epi-
didymal sperm number) in the absence of
changes in parental body weight. Although
alopecia may be taken as evidence of"gen-
eral toxicity," it is unlikely to "cause" the
reproductive effects in the same way that,
for example, hepatic or renal toxicity may
adversely impact reproductive capability.
Still unaddressed by this study is the possi-
bility that early exposure may adversely
influence the development ofthe reproduc-
tive system, as modeled in rodents.
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Summary: NTP Reproductive Assessment by Continuous Breeding Study.
NTIS#: PB85204659/AS
Chemical: Theophylline
CAS#: 58-55-9
Mode of exposure: Feed
Species/strain: Swiss CD-1 mice
F generaton Dose concentration |0.075 0.15% -03%
Waterconsumption 0
Clinicalsigns t t tt
Kilitters/pair _ _* _, _
#livepups/litter, pupwiitter-
Cumulative days to lifter T -
Absolutetestis, epididymisweight _
Sex accessoryglandweight"(prostate,seminalvesicle) _____________
Epidid. sperm parameters (,motility,morphology)
Estrous cyclelength_
[Determination ofaffected sex(crossover) ]Male ]Female [Both
Dose level 0uw.l3% _ ___ _ ______1
ration Dose concentration-
.............._
Pup growth to weaning
Mortality
Adultbodyweight**
Kidneyweighta ____________
Uiverweight8a___________
Feedconsumption c
Water consumption
Clinical signs toweaning_.* _
Fertilityindex__
livepups/litter;lpup wi/litter
Absolutetestis,epididymisweight8 . . -
Sexaccessoryglandweight (prostate,seminalvesicle)
Epidid.sparm parameters(#.motility,morphology)
..
Estrous cycle_length
Affected sex? Female
Study confounders: None
NOAELreproductivetoxicity: <.015%
NDAELgeneraltoxicity: <.015%
FA more sensitivethan Fe? Unknown
Postnatal toxicity: Unknown
Legend: -, no change; e, no observation;sm or , statistically significant change (p0.05); - no change in males orfemales. 9Adjusted for bodyweight.
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